Thymosin-β4 regulates motility and metastasis of malignant mouse fibrosarcoma cells

American Journal of Pathology

Volumn 160, Issue 3, 2002, Pages 869-882

  Kobayashi, Tokushige ^a   Okada, Futoshi ^a   Fujii, Nobuyuki ^b   Tomita, Naoko ^b   Ito, Satoru ^b   Tazawa, Hiroshi ^a   Aoyama, Tetsuya ^c   Choi, Sung Ki ^a   Shibata, Toshiyuki ^c,d,e   Fujita, Hisakazu ^a   Hosokawa, Masuo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b FUJIREBIO INC   (Japan)

^c Second Department of Oral and Maxillofacial Surgery   (Japan)

^d HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^e GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA; F ACTIN; G ACTIN; MESSENGER RNA; THYMOSIN BETA4; THYMOSIN; THYMOSIN BETA(4);

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CELL MOTILITY; CELL SHAPE; CONTROLLED STUDY; CYTOSKELETON; DIFFERENTIAL DISPLAY; FIBROSARCOMA; GENE OVEREXPRESSION; LUNG METASTASIS; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CANCER TRANSPLANTATION; CELL CULTURE; CELL MOTION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; LUNG TUMOR; PATHOLOGY;

ANIMALS; CELL MOVEMENT; FIBROSARCOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; THYMOSIN; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036005849     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64910-3     Document Type: Article

References (58)

1. Evidence for a novel gene associated with low tumor metastatic potential
2. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene
3. 2+-binding protein family
4. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
5. Malignant progression of a mouse fibrosarcoma by host cells reactive to a foreign body (gelatin sponge)
6. Progression of a weakly tumorigenic mouse fibrosarcoma at the site of early phase of inflammation caused by plastic plates
7. Inflammatory cell-mediated tumour progression and minisatellite mutation correlate with the decrease of antioxidative enzymes in murine fibrosarcoma cells
8. Activated leukocyte cell adhesion molecule (ALCAM) and annexin II are involved in the metastatic progression of tumor cells after chemotherapy with adriamycin
9. Tumor progression accelerated by oxygen species and its chemoprevention
10. Single treatment with cisplatin or UFT, but not their combination treatment enhances the metastatic capacity of mouse fibrosarcoma cells
11. Regression mechanisms of mouse fibrosarcoma cells after in vitro exposure to quercetin: Diminution of tumorigenicity with a corresponding decrease in the production of prostaglandin E2
12. Enhancement of in vitro prostaglandin E2 production by mouse fibrosarcoma cells after co-culture with various anti-tumour effector cells
13. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction
14. Increased E1AF expression in mouse fibrosarcoma promotes metastasis through induction of MT1-MMP expression
15. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
16. Enhancing effects of epidermal growth factor on human squamous cell carcinoma motility and matrix degradation but not growth
17. Effects of thymosin β4 and thymosin β10 on actin structures in living cells
18. Polyamine depletion alters the relationship of F-actin, G-actin, and thymosin β4 in migrating IEC-6 cells
19. Complete amino acid sequence of bovine thymosin beta 4: A thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations
20. Thymosin beta 4 sequesters the majority of G-actin in resting human polymorphonuclear leukocytes
21. Beta thymosins as actin binding peptides
22. Thymosin beta 10 and thymosin beta 4 are both actin monomer sequestering proteins
23. Interaction of G-actin with thymosin beta 4 and its variants thymosin beta 9 and thymosin beta met9
24. Expression of the thymosin beta 4 gene during differentiation of hematopoietic cells
25. Differential expression of the human thymosin-beta-4 gene in lymphocytes, macrophages, and granulocytes
26. Isolation and structural characterization of thymosin-beta 4 from a human medullary thyroid carcinoma
27. Differential expression of thymosin genes in human tumors and in the developing human kidney
28. Genomic analysis of metastasis reveals an essential role for Rho C
29. β-thymosins are not simple actin monomer buffering proteins
30. Thymosin B15: A novel regulator of tumor motility upregulated in metastatic prostate cancer
31. Thymosin beta-10 gene overexpression is a general event in human carcinogenesis
32. Localization and quantitation of expression of the cell motility-related protein thymosin beta15 in human breast tissue
33. Thymosin beta-10 gene overexpression correlated with the highly malignant neoplastic phenotype of transformed thyroid cells in vivo and in vitro
34. Thymosin beta15 expression in tumor cell lines with varying metastatic potential
35. Motility of rat ascites hepatoma cells, with reference to malignant characteristics in cancer metastasis
36. In vitro motility of cells from human epidermold carcinomas. A study by phase-contrast and reflection-contrast cinematography
37. Thymosin β4 in cultured mammalian cell lines
38. Co-ordinate regulation of the cytoskeleton in 3T3 cells overexpressing thymosin-β4
39. Modulation of myoepithelial-associated α6β4 integrin in a breast cancer cell line alters invasive potential
40. F-actin binding site masked by the intramolecular association of vinculin head and tail domains
41. Regulation of vinculin binding to talin and actin by phosphtidyl-inositol-4-5-bisphosphate
42. 125FAK
43. Tyrosine phosphorylation of paxillin and focal adhesion kinase during insulin-like growth factor-1-stimulated lamellipodial advance
44. Insulin and insulin-like growth factor-1 stimulate dephosphorylation of paxillin in parallel with focal adhesion kinase
45. FAK focal adhesion kinase is a substrate for the insulin and insulin-like growth factor-1 tyrosine kinase receptors
46. Thymosin β4 serves as a glutaminyl substrate of transglutaminase. Labeling with fluorescent dansylcadaverine does not abolish interaction with G-actin
47. Identification of cytoplasmic actin as an abundant glutaminyl substrate for tissue transglutaminase in HL-60 and U937 cells undergoing apoptosis
48. Molecular interactions between G-actin, DNase I and the beta-thymosins in apoptosis: A hypothesis
49. Matrigel induces thymosin beta 4 gene in differentiating endothelial cells
50. Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells
51. Biochemical and antibacterial analysis of human wound and blister fluid
52. Thymosin beta 4 (T beta 4) in activated platelets
53. Thymosin beta-4 expression is correlated with metastatic capacity of colorectal carcinomas
54. β-thymosins, small acidic peptides with multiple functions
55. The sulfoxide of thymosin beta 4 almost lacks the polymerization-inhibiting capacity for actin
56. Thymosin β4 sulfoxide is an antiinflammatory agent generated by monocytes in the presence of glucocorticoids
57. Function of maspin
58. p53 regulates the expression of the tumor suppressor gene maspin